0000899243-22-030924.txt : 20220913
0000899243-22-030924.hdr.sgml : 20220913
20220913162751
ACCESSION NUMBER: 0000899243-22-030924
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220719
FILED AS OF DATE: 20220913
DATE AS OF CHANGE: 20220913
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Nader Francois
CENTRAL INDEX KEY: 0001365343
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40384
FILM NUMBER: 221241063
MAIL ADDRESS:
STREET 1: 550 HILLS DRIVE
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Talaris Therapeutics, Inc.
CENTRAL INDEX KEY: 0001827506
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 570 PRESTON ST.
STREET 2: SUITE 400
CITY: LOUISVILLE
STATE: KY
ZIP: 40202
BUSINESS PHONE: 502-398-9250
MAIL ADDRESS:
STREET 1: 93 WORCESTER STREET
CITY: WELLESLEY
STATE: MA
ZIP: 02481
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0306
4/A
2022-07-19
2022-07-25
0
0001827506
Talaris Therapeutics, Inc.
TALS
0001365343
Nader Francois
C/O TALARIS THERAPEUTICS, INC.
93 WORCESTER STREET
WELLESLEY
MA
02481
1
0
0
0
Common Stock
2022-07-19
4
P
0
50000
3.52
A
50000
D
Common Stock
2022-07-20
4
P
0
52000
3.62
A
102000
D
Common Stock
2022-07-21
5
J
0
E
248432
0.00
D
147255
I
By Francois Nader 2020 Trust
Common Stock
2022-07-21
5
J
0
E
248432
0.00
A
248432
I
By FN TALS LLC
Common Stock
2022-07-21
4
P
0
36500
3.72
A
138500
D
Common Stock
2022-07-25
5
J
0
E
138500
0.00
D
0
D
Common Stock
2022-07-25
5
J
0
E
138500
0.00
A
386932
I
By FN TALS LLC
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.38 to $3.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.51 to $3.66, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Represents the transfer of shares held by the Francois Nader 2020 Trust to FN TALS LLC for no consideration.
These shares are held in a trust for the benefit of the Reporting Person's spouse and child. The Reporting Person''s spouse and child are trustees of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
These shares are held by a limited liability company of which the Reporting Person serves as the sole member, with sole voting and investment control over the securities held thereby. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.595 to $3.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Represents the transfer of shares held by the Reporting Person to FN TALS LLC for no consideration.
This amendment is being filed solely to correct the number of shares reported by the Francois Nader 2020 Trust, which was incorrectly reported due to an administrative error.
/s/ Mary Kay Fenton, attorney-in-fact
2022-09-13